TheraRadar
← Back
Data updated: May 24, 2026

CHARTWELL RX

Generics

CHARTWELL RX is a generic drug manufacturer focused on Cardiovascular, Neurology, Infectious Disease. Key products include ACTICLATE.

1971
Since
340
Drugs
-
Trials
1
New Drugs (2yr)
Modality:
2 Small Molecules

Therapeutic Areas

Disease areas where this company has approved drugs and active pipeline. Weighted by commercial stage: approved drugs count most, followed by late-stage trials.

Cardiovascular 35%
29 drugs
Neurology 25%
21 drugs
Infectious Disease 19%
16 drugs
Dermatology 13%
11 drugs
Respiratory 7%
6 drugs

Pipeline Snapshot

Active clinical trials across all therapeutic areas. Data from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • ACTICLATE leads revenue
  • 5 key drugs tracked

Trial Catalysts

  • Cardiovascular pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling